These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 29217096)

  • 1. Trend and seasonality of community-acquired Escherichia coli antimicrobial resistance and its dynamic relationship with antimicrobial use assessed by ARIMA models.
    Asencio Egea MÁ; Huertas Vaquero M; Carranza González R; Herráez Carrera Ó; Redondo González O; Arias Arias Á
    Enferm Infecc Microbiol Clin (Engl Ed); 2018 Oct; 36(8):502-506. PubMed ID: 29217096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Seasonal variation in antimicrobial resistance rates of community-acquired Escherichia coli bloodstream isolates.
    Ramsey EG; Royer J; Bookstaver PB; Justo JA; Kohn J; Albrecht H; Al-Hasan MN
    Int J Antimicrob Agents; 2019 Jul; 54(1):1-7. PubMed ID: 30885805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimicrobial susceptibility of clinical Escherichia coli isolates from uncomplicated cystitis in women over a 1-year period in Spain.
    Gobernado M; Valdés L; Alós JI; García-Rey C; Dal-Ré R; García-de-Lomas J;
    Rev Esp Quimioter; 2007 Mar; 20(1):68-76. PubMed ID: 17530038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial susceptibility of Escherichia coli from community-acquired urinary tract infections in Europe: the ECO·SENS study revisited.
    Kahlmeter G; Poulsen HO
    Int J Antimicrob Agents; 2012 Jan; 39(1):45-51. PubMed ID: 22055529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary Escherichia coli antimicrobial susceptibility profiles and their relationship with community antibiotic use in Tasmania, Australia.
    Meumann EM; Mitchell BG; McGregor A; McBryde E; Cooley L
    Int J Antimicrob Agents; 2015 Oct; 46(4):389-93. PubMed ID: 26187365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends, seasonality and the association between outpatient antibiotic use and antimicrobial resistance among urinary bacteria in the Netherlands.
    Martínez EP; van Rosmalen J; Bustillos R; Natsch S; Mouton JW; Verbon A
    J Antimicrob Chemother; 2020 Aug; 75(8):2314-2325. PubMed ID: 32417922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intra-hospital differences in antibiotic use correlate with antimicrobial resistance rate in
    Cusini A; Herren D; Bütikofer L; Plüss-Suard C; Kronenberg A; Marschall J
    Antimicrob Resist Infect Control; 2018; 7():89. PubMed ID: 30069305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Changes in the antimicrobial susceptibility of Escherichia coli isolates from nosocomial versus community-acquired urinary tract infections].
    Junquera S; Loza E; Baquero F
    Enferm Infecc Microbiol Clin; 2005 Apr; 23(4):197-201. PubMed ID: 15826543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for ciprofloxacin resistance among Escherichia coli strains isolated from community-acquired urinary tract infections in Turkey.
    Arslan H; Azap OK; Ergönül O; Timurkaynak F;
    J Antimicrob Chemother; 2005 Nov; 56(5):914-8. PubMed ID: 16174685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-hospital antimicrobial usage and resistance in community-acquired Escherichia coli urinary tract infection.
    Kahlmeter G; Menday P; Cars O
    J Antimicrob Chemother; 2003 Dec; 52(6):1005-10. PubMed ID: 14613955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modelling the impact of antibiotic use on antibiotic-resistant Escherichia coli using population-based data from a large hospital and its surrounding community.
    Vernaz N; Huttner B; Muscionico D; Salomon JL; Bonnabry P; López-Lozano JM; Beyaert A; Schrenzel J; Harbarth S
    J Antimicrob Chemother; 2011 Apr; 66(4):928-35. PubMed ID: 21393172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Etiology of community-acquired lower urinary infections and antimicrobial resistance of Escherichia coli: a national surveillance study].
    Andreu A; Planells I;
    Med Clin (Barc); 2008 Apr; 130(13):481-6. PubMed ID: 18423165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. E. coli, K. pneumoniae and K. oxytoca community-acquired infections susceptibility to cephalosporins and other antimicrobials in Lebanon.
    Moghnieh RA; Musharrafieh UM; Husni RN; Abboud E; Haidar M; Abboud E; Abou Shakra D
    J Med Liban; 2014; 62(2):107-12. PubMed ID: 25011373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Temporal changes in the prevalence of community-acquired antimicrobial-resistant urinary tract infection affected by Escherichia coli clonal group composition.
    Smith SP; Manges AR; Riley LW
    Clin Infect Dis; 2008 Mar; 46(5):689-95. PubMed ID: 18230040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In-vitro susceptibility of quinolone-resistant clinical isolates of Escherichia coli to fosfomycin trometamol.
    Ungheri D; Albini E; Belluco G
    J Chemother; 2002 Jun; 14(3):237-40. PubMed ID: 12120876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Five-Year Antimicrobial Resistance Patterns of Urinary Escherichia coli at an Australian Tertiary Hospital: Time Series Analyses of Prevalence Data.
    Fasugba O; Mitchell BG; Mnatzaganian G; Das A; Collignon P; Gardner A
    PLoS One; 2016; 11(10):e0164306. PubMed ID: 27711250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ciprofloxacin resistance in community- and hospital-acquired Escherichia coli urinary tract infections: a systematic review and meta-analysis of observational studies.
    Fasugba O; Gardner A; Mitchell BG; Mnatzaganian G
    BMC Infect Dis; 2015 Nov; 15():545. PubMed ID: 26607324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Aspects of the antimicrobial resistence profile in infections with Escherichia coli and Klebsiella pneumoniae in diabetic patients].
    Petrovici CG; Dorobăţ C; Matei M; Teodor A; Luca V; Miftode E
    Rev Med Chir Soc Med Nat Iasi; 2011; 115(3):769-75. PubMed ID: 22046785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antibiotic resistance of Escherichia coli from community-acquired urinary tract infections. What antimicrobial to use?].
    Guajardo-Lara CE; González-Martínez PM; Ayala-Gaytán JJ
    Salud Publica Mex; 2009; 51(2):155-9. PubMed ID: 19377743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Basic patient characteristics predict antimicrobial resistance in E. coli from urinary tract specimens: a retrospective cohort analysis of 5246 urine samples.
    Erb S; Frei R; Tschudin Sutter S; Egli A; Dangel M; Bonkat G; Widmer AF
    Swiss Med Wkly; 2018 Nov; 148():w14660. PubMed ID: 30440065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.